The Deal magazine looks at the biotech sector and how new, creative funding deals are promising to rejuvenate the search for new drugs. Plus, this issue looks at LIBOR's new landscape. Meanwhile, we have an indepth conversation with CD&R's Joseph Rice.June 18, 2012
What goes up must come down, and so it would appear as The Deal magazine examines big-league bankruptcy. The theory holds for Tribune as it's new owners weigh its assets. But what about W.R. Grace, as it emerges from bankruptcy having made 22 acquisitions under protection? Plus, the corporate dealmaker 100.May 28, 2012
The Deal magazine takes an indepth look at the strategic dealmaking of the packaging industry in the middle market. We also hit the road looking at the startup landscape in the drug development and medical devices sectors in Kalamazoo, Michigan as well as the burgeoning companies in the solar power, pharmaceutical, brewery and pesticide industries in Bend, Oregon.May 7, 2012
Wanna do M&A? Careful, because here comes the shareholder litigation. When it comes to tech acquisitions, they're getting done -- just too bad companies aren't very good at it. And sovereign wealth funds are back, growing fast.April 16, 2012
No one said private equity would be easy, and our annual Private Equity Deals of the Year proves it again with a roundup of 2011's big winners and losers. Also, The Deal magazine takes a look at cowboy capitalism with a trip to Dallas-Fort Worth. Finally, take a look at our sampling of middle-market companies on the auction block.April 2, 2012
The Deal magazine travels to Japan to witness the island nation rise again amidst an active streak of dealmaking. Plus, a duet of music-related articles look at the antitrust snares of Universal Music's purchase of EMI assets and the effect that the emergence of digital music is having on copyright laws.March 12, 2012
In this issue, The Deal magazine hits the bankruptcy trifecta: the take-no-prisoners battle for Alter Communications; the rise and fall of real estate moguls, the Meruelo brothers; and the bankruptcy league tables. Also, take a look at how Humana has set a new course along the acquisition trail.February 20, 2012
The Deal magazine focuses on the middle market by looking at some of its top dealmakers and then gives an overview of what's out there on the auction block. The issue also features an in-depth look at private equity in France and in emerging markets around the world.February 6, 2012
The Deal magazine gets in the pilot seat to take a look at American Airlines' bankruptcy, then wonders what will now happen to a beleaguered Reader's Digest. Also, Herb Fritch of HealthSpring may have an answer to the sky-high inflation of the healthcare industry.January 23, 2011
What a topsy-turvy, rumbly-tumbly year 2011 turned out to be -- and The Deal magazine takes a look at the M&A Deals of the Year in uncertain times. Also, Edgar Bronfman Jr. sits down for his first interview since selling Warner Music.December 12, 2011
Just when you thought it was safe to go back in the water, suddenly it was 2011 -- and The Deal magazine looks back at all the twists and turns of dealmaking. Also in this issue, dealmakers pay back as social entrepreneurs.November 28, 2011
'What worrying wall of debt?' The Deal magazine asks. Oh, right, there it is. Plus, the Windy City offers up its own particular brand of private equity, while, farther afield, Big Oil makes a play in Kurdistan.November 14, 2011
The Deal magazine tracks down the in-house corporate dealmakers from the top American companies and takes a voyage around the world to explore the valleys and peaks of the travel industry.October 31, 2011
The Deal magazine goes back to school and offers a full report on the business of education.October 17, 2011
The Deal magazine goes looking for trolls and geeks, and the middle market shows its ups and downs in a trying economy.October 3, 2011
Who are the private equity movers and shakers to keep an eye on, and how does Ralph de la Torre look to transform managed care?September 19, 2011
The Deal magazine honors this year's Most Admired Corporate Dealmakers and takes a close look at the ups and downs of Wall Street compensation.September 5, 2011
The interview issue asks all the pertinent questions to six experts in their respective fields, while the market for multiple sclerosis therapies provides an evocative case study on dealmaking.July 25, 2011
The Deal magazine gets up close and personal with faces of the middle market and charts the new hits of the music business as it shifts away from label dominance.June 27, 2011
Despite trying financial times, the spotlight shines on the private equity deals of the year that were deftly executed and held to the principle of creating value.
Paul Hastings Partner Tara Giunta speaks about the dearth of female board members in Corporate America.
Cleary Gottlieb's Senior Counsel Edward Greene on Europe, Dodd Frank and bank M&A.
Icebreaker's founder and managing director offers a unique venture financing to music artists when she's not trekking to one of the poles.
The former Credit Suisse investment banker gives up dealmaking to join J.P. Morgan in a strategic role.
The attorney who defended Lundbeck in an antitrust case contends that price increases would have happened with or without the company's acquisition of NeoProfen.
U.S. companies have been slow to buy in the Middle Kingdom, but some say that's about to change.
A deal with Intel that includes 190 patents and 170 patent applications will net Nielsen's company $120 million.
An avoidable row over the compensation of the Royal Bank CEO has left him, the bank's board and Prime Minister Cameron diminished and humiliated.
New hires at both Kirkland and Dewey & LeBouef pay off, and Apache remains faithful to Goldman.
One of the least-famous figures around is about to go public, and so is his company.
A group of hedge funds staged an insurrection at Reader's Digest, tossing out the board and losing CEO Mary Berner a week later. Then it got complicated.
A bitter election season is under way, and Washington will become even more stopped up than ever. Nevertheless, expect some real movement on a variety of issues affecting deals.
The HealthSpring executive believes he has the managed-care model that can really restrain costs.
Despite anti-elitist murmurings, the electronic news service embraces Davos as an opportunity to use its stable of name journalists to test a proof-of-concept magazine. No, it's not called Portfolio.
Enough with the talking point. There are real questions worth asking about private equity.
Confidentiality agreements factor prominently in Martin Marietta-Vulcan and Westlake Chemical-Georgia Gulf, offering a rare glimpse at the drafting issues involved.
Nonfinancial institutions might be in line to buy banks if the purchase of Bonneville Bancorp offers any guidance.
These sales are now accepted as an invaluable tool not just for disposing unwanted assets or raising cash, but for managing investment portfolios.
If the euro crisis gets worse, the economic climate in U.S. and China will rapidly deteriorate, but some recent changes could ameliorate the situation.
Buyers and sellers should be mindful of the Delaware Supreme Court regarding Liberty Media on whether a shareholder vote or lender consent would be required to approve such divestitures.
If the decision leads to substantially greater litigation, the ruling may cause securities advisers to reconsider their strategies and follow more conservative investment approaches.